CME Presentations

Hormonal Therapy


Presentations


Speakers


CME Information

Hormonal Therapy for Prostate Cancer: Constructing Well-Defined Clinical Decisions


  

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Adhere to current guidelines on the treatment of patients with advanced prostate cancer
  • Review latest evidence-based recommendations for selecting an ADT and dosing schedule
  • Plan strategies to improve the management of treatment-related adverse events in patients with advanced prostate cancer
  • Incorporate collaborative care and shared decision-making processes into the clinical care of patients with advanced prostate cancer

Acknowledgement

This activity is supported by an educational grant from AbbVie Inc.

Tuition

Complimentary

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Live Internet Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Releasae/Expiration

Live Activity
Tuesday, February 5, 2019 from 1:00pm – 2:00pm EST.

Enduring Material
The enduring material will be available from February 5, 2019 to February 5, 2020.

Target Audience

This activity is intended for urologists with a secondary audience of medical and genitourinary oncologists, surgeons, and other health care providers who care for or have an interest in patients with advanced prostate cancer

Estimated Time to Complete

This activity consists of one session which should take approximately 1 hour to complete.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

Neal D. Shore, MD, FACS
Medical Director, CPI
Carolina Urologic Research Center
Atlantic Urology Clinics


Consulting Fees: Astellas, Amgen, AstraZeneca, Bayer, Bristol-Myers-Squibb, Dendreon, Ferring, Janssen, Merck, MDxHealth, Myriad, Nymox, Pfizer, Sanofi-Genzyme, Tolmar

Michael S. Cookson, MD
Professor and Chairman, Department of Urology
University of Oklahoma Health Sciences Center

Consulting Fees: Astellas, Bayer, Janssen, MDxHealth, Precision Biopsy

Alicia K. Morgans, MD, MPH
Associate Professor of Medicine
Northwestern University Feinberg School of Medicine

Consulting Fees: Astellas, AstraZeneca, Bayer, Sanofi, Genentech, Janssen

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Agnes Lee, PhD
Medical Director
PlatformQ Health Education, LLC

None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Discalimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Technical Support:
For any technical issues or issues with your CME Certificate, please contact UroCareLive or OMedLive at 877-394-1306 or at Support@UroCareLive.com